# Bard Access Systems, Inc. (C.R. Bard, Inc.)

- Location (FDA's records): Salt Lake Ciy,, UT
- FDA decisions: 3 (2021–2024): 3 510(k) clearances
- Product codes: IYO (2), FOZ (1)
- 510(k) review time since 2016: median 131 days, against 177 for FDA's reviews in the same codes and years (1 of 3 faster)
- Predicates its devices cite: 3 (0 its own); citations of its devices by later devices: 2 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- C. R. Bard: 2 (https://510kreport.com/company/c-r-bard)
- C.R. Bard, Inc.: 1 (https://510kreport.com/company/cr-bard)

## Firms that cite its devices most
- X9, Inc.: 1 (https://510kreport.com/company/x9)
- Bard Access Systems, Inc.: 1 (https://510kreport.com/company/bard-access-systems)

## Its most-cited devices
- K211193: BD Prevue II Peripheral Vascular Vascular Access System (2021), cited by 2

## Recent decisions
- K233106: AccuCath Ace™ Intravascular Catheter (Apr 19, 2024)
- K231283: SiteRite™ 9 Ultrasound System (Sep 11, 2023)
- K211193: BD Prevue II Peripheral Vascular Vascular Access System (Jun 25, 2021)

Source page: https://510kreport.com/company/bard-access-systems-cr-bard